Clinical Trials

Showing trials with last updates posted in 2022.

NCT03488251 | TERMINATED | PHASE2
8 participants

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-16
Start Date:
2018-08-20
Completion:
2021-03-12
Conditions
  • Non-hodgkin Lymphoma,B Cell
  • Refractory Diffuse Large B-Cell Lymphoma
  • Relapsed Diffuse Large B-Cell Lymphoma
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page